Significant weight gain in CLL patients treated with Ibrutinib: A potentially deleterious consequence of therapy

AMERICAN JOURNAL OF HEMATOLOGY

WILEY

1. National Cancer Institute at the National Institutes of Health [F99CA222742]
2. Cadregari Endowment Fund